Small-cell carcinoma of the lung detected by CT screening: Stage distribution and curability

Lung Cancer

Volumn 76, Issue 3, 2012, Pages 339-343

  Austin, John H M ^a   Yip, Rowena ^b   D'Souza, Belinda M ^a   Yankelevitz, David F ^b   Henschke, Claudia I ^b,c  

^a Department of Medicine   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c ARIZONA STATE UNIVERSITY   (United States)

Author keywords

CT; Lung cancer; Lung neoplasm; Screening; Small cell carcinoma

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CHI SQUARE TEST; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; FISHER EXACT TEST; HUMAN; KAPLAN MEIER METHOD; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

AGED; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SMALL CELL LUNG CARCINOMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84860539405     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2011.11.017     Document Type: Article

References (31)

1. Sculier J.-P., Chansky K., Crowley J.J., Meerbeeck J.V., Goldstraw P. The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th edition of the TNM classification of malignant tumors and the proposals for the 7th edition. J Thorac Oncol 2008, 3:457-466. International Staging Committee of the International Association for the Study of Lung Cancer.
2. Govindan R., Page N., Morgensztern D., Read W., Tierney R., Vlahiotis A., Spitznagel E.L., et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006, 24:4539-4544.
3. Janssen-Heijnen M.L.G., Coebergh J.W.W. Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe. Lung Cancer 2001, 31:123-137.
4. Spiro S.G., James L.E., Rudd R.M., Trask C.W., Tobias J.S., Snee M., et al. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis. J Clin Oncol 2006, 24:3823-3830.
5. Lester J.F., Hudson E., Flubacher M., et al. Small cell lung cancer treated in southeast Wales. Clin Oncol 2006, 18:378-382.
6. Sundstrøm S., Bremnes R.M., Kaasa S., Aasebo, Aamdal S. Second-line chemotherapy in recurrent small cell lung cancer: results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen). Lung Cancer 2005, 48:251-261. Norwegian Lung Cancer Study Group.
7. Ou S.H.I., Zell J.A. The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th TNM edition. J Thorac Oncol 2009, 4:300-310.
8. Shepherd F.A., Crowley J., Van Houtte P., Postmus P.E., Carney D., Chansky K., et al. The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. J Thorac Oncol 2007, 2:1067-1077.
9. Yu J.B., Decker R.H., Detterbeck F.C., Wilson L.D. Surveillance epidemiology and end results evaluation of the role of surgery for stage I small cell lung cancer. J Thorac Oncol 2010, 5:215-219.
10. Vallières E., Shepherd F.A., Crowley J., Van Houtte P., Postmus P.E., Carney D., et al. The IASLC proposals regarding the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification of lung cancer. J Thorac Oncol 2009, 4:1029-1059.
11. Asamura H., Goya T., Koshiishi Y., Sohara Y., Eguchi K., Mori M., et al. A Japanese lung cancer registry study: prognosis of 13,010 resected lung cancers. J Thorac Oncol 2008, 3:46-52.
12. Wilson D.O., Weissfeld J.L., Fuhrman C.R., Fisher S.N., Balogh P., Landdreneau R.J., et al. The Pittsburgh lung screening study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med 2008, 178:956-961.
13. Sone S., Nakayama T., Honda T., Tsushima K., Li F., Haniuda M., et al. CT findings of early-stage small cell lung cancer in a low-dose CT screening programme. Lung Cancer 2007, 56:207-215.
14. Henschke C.I., Yankelevitz D.F., Mietinnen O.S. Computed tomographic screening for lung cancer: the relationship of disease stage to tumor size. Arch Intern Med 2006, 166:321-325. International Early Lung Cancer Action Program Investigators.
15. The National Lung Screening Trial Research Team Reduced lung cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011, 365:395-409.
16. Henschke CI. International early lung cancer action program: enrollment and screening protocol. [accessed 11.07.11]. http://www.ielcap.org/.
17. Sobin L.H., Wittekind C. TNM classification of malignant tumours 2002, Wiley-Liss, New York. 6th ed.
18. Vasquez M, Flieder D, Travis W, Carter D, Yankelevitz D, Miettinen OSM, et al. Early lung cancer action project pathology protocol. [accessed 11.07.11]. http://www.ielcap.org/.
19. Brueckl W.M., Herbst L., Lechler A., Fuchs F., Schoeberl A., Zirlik S., et al. Predictive and prognostic factors in small cell lung carcinoma (SCLC): analysis from routine clinical practice. Anticancer Res 2006, 26:4825-4832.
20. Bremnes R.M., Sundstrom S., Aasebø U., Kaasa S., Hatlevoll R., Aamdal S., et al. The value of prognostic factors in small cell lung cancer: results from a randomized multicenter study with minimum 5 year follow-up. Lung Cancer 2003, 39:303-313.
21. Black W.C., Welch H.G. Screening for disease. AJR Am J Roentgenol 1997, 168:3-11.
22. Shepherd F.A. Surgery for limited stage small cell lung cancer: time to fish or cut bait. J Thorac Oncol 2010, 5:147-149.
23. Bayman N.A., Sheikh H., Kularatne B., Lorigan P., Blackhall F., Thatcher N., et al. Radiotherapy for small-cell lung cancer: where are we heading?. Lung Cancer 2008, 63:307-314.
24. Badzio A., Kurowski K., Karnicka-Mlodkowska H., Jassem J. A retrospective comparative study of surgery followed by chemotherapy vs. non-surgical management in limited-disease small cell lung cancer. Eur J Cardiothorac Surg 2004, 26:183-188.
25. Henschke C.I., Smith J.P., Miettinen O.S. Answers to letters. NEJM 2007, 356:743-747.
26. Muscat J.E., Wynder E.L. Lung cancer pathology in smokers, ex-smokers and never-smokers. Cancer Lett 1995, 88:1-5.
27. Niho S., Fujii H., Murakami K., Nagase S., Yoh K., Goto K., et al. Detection of unsuspected distant metastases and/or regional nodes by FDG-PET in LD-SCLC scan in apparent limited-disease small-cell lung cancer. Lung Cancer 2007, 57:328-333.
28. Brink I., Shumacher T., Mix M., Ruhland S., Stoelbel E., Digel W., et al. Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer. Eur J Nucl Med Mol Imaging 2004, 31:1614-1620.
29. Nicholson S.A., Beasley M.B., Brambilla E., Hasleton P.S., Colby T.V., Sheppard M.N., et al. Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens. Am J Surg Pathol 2002, 26:1184-1197.
30. Bepler G., Neumann K., Holle R., Havemann K., Kalbfleisch H. Clinical relevance of histologic subtyping in small cell lung cancer. Cancer 1989, 64:74-79.
31. Lim E., Belcher E., Yap Y.K., Nicholson A.G., Goldstraw P. The role of surgery in the treatment of limited disease small cell lung cancer: time to reevaluate. J Thorac Oncol 2008, 3:1267-1271.